Chandrasena Gillian 4

What Happened

• Chandrasena Gillian, Senior Vice President and Chief Human Resources Officer of MiniMed Group, Inc. (MMED), was granted two awards totaling 44,188 restricted stock units (RSUs) on July 1, 2026: 29,483 RSUs and 14,705 RSUs. Each grant was reported at $0.00 per share (awards/compensation), so there was no cash purchase — total reported value at grant = $0.
• These awards are compensation grants (not an open-market purchase or sale) and will convert to shares if and when they vest according to the vesting schedules below.

Key Details

• Transaction date: July 1, 2026. Filing date: July 6, 2026 (filed 5 days after the grant).
• Grant details and vesting:
  • 29,483 RSUs — vest in approximately equal one‑third increments on the 1st, 2nd and 3rd anniversaries of the grant date (footnote F1).
  • 14,705 RSUs — vest on the 3rd anniversary of the grant date (footnote F4).
• Price: $0.00 per share (award/grant), total reported immediate value $0.
• Footnotes of note:
  • F2 indicates these entries include shares to be issued upon vesting of RSUs.
  • F3 notes Gillian acquired 891 shares under MMED’s 2026 Employee Stock Purchase Plan on June 30, 2026.
• Shares owned after the transaction are not specified in the provided filing excerpt.
• Timeliness: The Form 4 was filed July 6 for a July 1 transaction, later than the standard two-business-day Form 4 reporting deadline.

Context

• RSU grants are compensation that vest over time; they do not represent an immediate market purchase or sale. Once vested, the RSUs convert into shares (and may be subject to tax withholding).
• For retail investors tracking insider activity, grants indicate company compensation/retention actions rather than a direct buy/sell signal. The late filing is procedural information to note but does not by itself indicate the insider’s intent.